|
|
|
|
|
|
|
|
| Advertisement |
No Cancer Left Behind: Drug Combination with Device Aims to Improve Cancer Outcomes
Innovation in oncology abounds, including innovations from surgery to therapeutics. During the initial cancer surgery, comprehensive removal of cancer cells improves patient outcomes. In this Q&A, Lumicell CEO Kelly Londy discusses new drug-device technology and clinical studies for a range of cancers to minimize the need for re-excisions – and the associated impact on cancer recurrence rates, complications, costs, and quality of life for patients.
 Read more here
|
|
| Advertisement |
GDPR: Implications for the global Life Sciences industry
Live Webcast: Wednesday, December 13 at 2:00pm EDT
 Register now
|
|
| Industry Trends |
 |
|
Taking Command of Strategy Execution |
Mark Bouch, Stephen Bungay, and David Roblin outline how the technique of “mission command,” a military approach to setting direction and executing strategy, could be used by pharma to address rising R&D costs and complexity.
... /Read more/ |
|
|
|
|
|
| Advertisement |
New Video Series! COMMERCIAL INSIGHTS into DIGITAL TRENDS
In this video series, produced in partnership with Veeva Systems, Pharmaceutical Executive speaks with biopharma and industry experts about the future of life sciences commercial capabilities and the hottest trends affecting this important market segment. Filmed live at the 9th Annual Veeva Systems' Global Commercial and Medical Summit.
 Learn more
|
|
|
|
|
|
|
|
